What long-term follow-up actually involves after prostate cancer treatment
Follow-up after prostate cancer treatment has two strands. The first is cancer control: tracking PSA, reviewing imaging when it is indicated, and checking whether any new symptoms need assessment. The second is function and quality of life: urinary control, sexual function, bowel habits and general wellbeing. Both strands matter, and they are reviewed differently depending on whether you had surgery, radiotherapy, focal treatment or are on active surveillance.
This guide is about the follow-up question, not about choosing a first treatment. If you are still deciding between options, that is a separate conversation with your treating team. If you have already been treated and want to organise ongoing review in China, the practical task is to build a plan that your Chinese hospital and your home clinician can both work from.
Radical prostatectomy removes the prostate for selected prostate cancers, and robotic instruments are controlled by the surgeon. That describes the operation itself. It does not tell you what your PSA should be afterwards, how often to test, or what continence and sexual function will look like. Those answers depend on your pathology, your treatment history and your own recovery, and only your treating clinicians can give them.
The records that make a follow-up plan possible
A follow-up plan built without your treatment history is guesswork. Before you ask any hospital in China to take on your long-term review, gather the documents that describe what was done and what has happened since.
The core set usually includes your original biopsy report with Gleason score or grade group, the prostate imaging you had before treatment, and the pathology report if you had surgery. If you had radiotherapy, keep the treatment summary with dates, technique and dose. If you are on active surveillance, bring every PSA result in sequence, not just the most recent one.
After treatment, the most useful record is a dated table of PSA values. A single number tells your new clinician very little; a trend over months or years shows whether the disease is stable. Add any imaging done since treatment, plus a short list of current medicines, allergies and other conditions.
You do not need to send a complete archive at first contact. A brief summary with your diagnosis, treatment dates and main question is enough to start. Ask the receiving hospital which documents it wants translated, and in what format, before you send anything.
Questions to ask before you commit to follow-up in China
The value of a follow-up arrangement depends on whether the hospital can actually deliver continuity. Ask directly, and ask for answers in writing where possible.
Who will review my PSA results, and how will I be told about them? What is the plan if a result changes? Which imaging would you order, and why? How do you decide when a change needs a biopsy or a scan rather than another test in a few months?
Then ask about the practical side. Can I have a named contact for results? Will reports be in English, or will I need translation? If I return home between visits, can we do some reviews remotely, and what are the limits of that? What would make you ask me to come back sooner?
These are not hostile questions. A hospital that can answer them clearly is better placed to share your care with your home clinician. A hospital that cannot answer them may still provide good treatment, but you should know what you are arranging before you rely on it.
Handover to your home clinician: what the plan must contain
The handover document is the part of follow-up that is easy to leave until later, and it is worth requesting before you finish your last appointment in China. Without it, your home doctor receives a stack of results with no interpretation and no plan.
Ask for a short summary that states your diagnosis and treatment history, the most recent PSA with its date, any imaging findings, current medicines, and the recommended follow-up interval. It should also say what would trigger a change in plan, such as a rising PSA or a new symptom.
Ask who wrote it and how your home clinician can contact that person if a question arises. This matters more than the length of the document. A one-page letter with a named contact is more useful than a long file with no owner.
If you are planning to move between countries during follow-up, raise this early. Some reviews can be done remotely with records; others need you present. Ask the hospital which is which for your case, rather than assuming either way.
Function, symptoms and the questions that are easy to postpone
Cancer control tends to dominate follow-up conversations, but urinary, sexual and bowel function affect daily life and are worth raising at every review. Do not wait for your clinician to ask. If you have leakage, difficulty emptying your bladder, pain, blood in urine or new bone pain, say so at the appointment.
The reason this strand is easy to postpone is that it rarely appears on a scan or a PSA report. A rising PSA and a worsening symptom are different signals, and they may point to different next steps. Your treating team decides what each one means for you. What you can do is make sure the functional side is not lost between the cancer-control checks.
Some of these symptoms have treatable causes and some need investigation. Your treating team decides which. What you can do is keep a simple record of when symptoms started, how often they occur and what makes them better or worse. That record is more useful than a general description, and it gives the clinician something concrete to work from.
If you are on hormone therapy or other ongoing medication, ask how your follow-up plan accounts for side effects and monitoring. Ask which side effects the plan expects to track, how often, and who you should contact if one becomes difficult to manage. Do not change or stop any prescribed medicine on your own, and do not delay assessment of new or worsening symptoms because you are planning a trip to China.
Sexual function deserves the same directness. If you had surgery, radiotherapy or hormone treatment, ask what changes are expected, what may improve over time and what options exist if they do not. These are clinical questions for your treating team, not something to research alone and then raise months later.
Bowel habits matter too, particularly after radiotherapy. If you notice new urgency, bleeding or a persistent change, report it rather than waiting for the next scheduled review. The same applies to any new pain that does not settle.
It also helps to decide in advance who you will tell about these symptoms. If your follow-up is shared between a Chinese hospital and a clinician at home, both should hear the same description. A short written note you can hand to either team keeps that consistent.
One practical habit is to write your three main concerns before each appointment and hand the list to the clinician at the start. It keeps the conversation on what matters to you, rather than only on the latest test result.
Costs, coordination and the next practical step
Follow-up in China involves hospital charges for consultations, PSA tests, imaging and any procedures, plus any coordination or interpretation services you choose to use. These are separate. Hospital fees are paid to the hospital; coordination fees are separate. Without your records, no one can give you a meaningful estimate, because the tests and visits depend on your case.
Ask the hospital for a written outline of what a follow-up visit includes, what is not included, and what remains undecided until your records are reviewed. That is more useful than a headline number.
If you want help identifying a suitable urology or oncology route in China, you can start with a free initial case review. Send a brief summary: your diagnosis, treatment dates, most recent PSA and your main question. Our team checks what is available, identifies missing information and suggests the relevant next step. This is not a diagnosis and does not confirm hospital acceptance. The hospital decides whether it can take on your follow-up.
For patients who want a records-based opinion before travelling, a proxy consultation is available but optional. It is not a prerequisite for an appointment. The relevant procedure reference for robotic radical prostatectomy is linked below if you are also reviewing surgical options.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.